Updated Jul 16, 2026
Skelton Laurence Matthew is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $66K.
Laurence Matthew Skelton is associated with Vera Therapeutics, Inc., a biotechnology company focused on developing therapies for patients with serious autoimmune diseases. Specific details about his role or contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-26 | VERA | Vera Therapeutics, Inc. | S — Open-market sale | 1.6K | $41.98 | $66K |
| 2026-02-07 | VERA | Vera Therapeutics, Inc. | A — Grant or award | 20.0K | $0.00 |
Laurence Matthew Skelton is associated with Vera Therapeutics, Inc., a biotechnology company focused on developing therapies for patients with serious autoimmune diseases. Specific details about his role or contributions to the company are not widely documented.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($66K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Skelton Laurence Matthew profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.